NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Gene Therapy



"Adenovirus-Mediated Gene Therapy of a Candidate Breast Tumor Suppressor Gene."



November 20th, 1995

According to an abstract submitted by the authors to the 4th International Conference on Gene Therapy of Cancer, held November 9-11, 1995, in San Diego, California, "H-Nuc is a candidate breast tumor suppressor gene which encodes an 824-amino acid protein. It was initially identified as CDC 27, the human homologue of Saccharomyces cerevisiae CDC 27, and mapped to human chromosome 17 q21-22, the same region as a candidate gene for early onset breast cancer (BRCA1). CDC 27 is a functional part of a complex which acts to ubiquitinate cyclin B. H-Nuc appears to bind hypophosphorylated Rb protein in the same region that SV40 large TAg binds. Conversely, Rb binds to...


Source: Cancer Weekly (1995-11-20)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login